Latest News

Testing Parkinson's disease immune-based drugs: New models

Using powerful, newly developed cell culture and mouse models of sporadic Parkinson?s disease (PD), researchers have demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain. By intercepting the distorted and misfolded alpha-synuclein (?-syn) proteins that enter and propagate in neurons, creating aggregates, the researchers prevented the development of pathology and also reversed some of the effects of already-existing disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Avoiding Neurodegeneration: Nerve cells borrow a trick from their synapses to dispose of garbage

  • People who suffer migraine headaches may be at double the risk of stroke

  • New stent devices fight strokes

  • Sea slug provides new way of analyzing brain data

  • Medulloblastoma: Promising drug target identified

  • Study adds evidence on link between PTSD, heart disease

  • Roseroot herb shows promise as potential depression treatment option

  • Testosterone needs estrogen's help to inhibit depression

  • Veterans' avoidant coping interfers with transition to university life

  • Crossing fingers can reduce feelings of pain

  •